chrX-54198512-C-T
Variant summary
Our verdict is Benign. The variant received -8 ACMG points: 0P and 8B. BP4_StrongBS2
The ENST00000354646.7(WNK3):c.5215G>A(p.Val1739Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000714 in 1,204,208 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 40 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
ENST00000354646.7 missense
Scores
Clinical Significance
Conservation
Publications
- Prieto syndromeInheritance: XL Classification: MODERATE Submitted by: G2P
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
WNK3 | NM_020922.5 | c.5215G>A | p.Val1739Ile | missense_variant | Exon 24 of 24 | NP_065973.2 | ||
WNK3 | NM_001002838.4 | c.5044G>A | p.Val1682Ile | missense_variant | Exon 23 of 23 | NP_001002838.1 | ||
WNK3 | NM_001395166.1 | c.5044G>A | p.Val1682Ile | missense_variant | Exon 23 of 23 | NP_001382095.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000184 AC: 2AN: 108767Hom.: 0 Cov.: 22 show subpopulations
GnomAD2 exomes AF: 0.000115 AC: 21AN: 182936 AF XY: 0.000223 show subpopulations
GnomAD4 exome AF: 0.0000767 AC: 84AN: 1095441Hom.: 0 Cov.: 30 AF XY: 0.000108 AC XY: 39AN XY: 361143 show subpopulations
GnomAD4 genome AF: 0.0000184 AC: 2AN: 108767Hom.: 0 Cov.: 22 AF XY: 0.0000319 AC XY: 1AN XY: 31329 show subpopulations
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.5215G>A (p.V1739I) alteration is located in exon 24 (coding exon 23) of the WNK3 gene. This alteration results from a G to A substitution at nucleotide position 5215, causing the valine (V) at amino acid position 1739 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at